Browsed by
Author: Simon McGrath

Bold plans for two big biomedical research projects

Bold plans for two big biomedical research projects

The ME/CFS Biomedical Partnership, led by Prof Chris Ponting and Dr Luis Nacul, plan a huge genetic study and a major expansion of the UK ME/CFS biobank. The partnership will give patients and their representatives a major role in planning and running the project. The genetic research, a genome-wide association study, would need to recruit 20,000 people with ME/CFS – and the researchers know they can only do with the support of the patient the community. A new research team…

Read More Read More

Launch of Canadian research network makes a big statement about M.E.

Launch of Canadian research network makes a big statement about M.E.

The Canadian government has announced a modest $1.4 million investment in a new research network and delivered a big message: ME is a serious illness, deserves respect (“Let’s remove the insult from this injury”) and needs more biomedical research. The network, led by Professor Alain Moreau, will set up a national patient cohort that will include objective data on patients’ posts-exertional malaise. It will initially run three studies, including a virus hunt. And it will boost Canadian research capacity, e.g….

Read More Read More

Researchers propose deep trawl of DNA to help uncover the causes of ME/CFS

Researchers propose deep trawl of DNA to help uncover the causes of ME/CFS

Analysing the DNA of thousands of patients can help to uncover the genetic roots of diseases and shed light on the underlying biological mechanisms. This can reveal targets for drug development. A new and very different type of genetic research has emerged this millennium – the genome-wide association study (GWAS, pronounced “gee-was”). By probing small genetic differences between people, such studies can help to uncover the biological roots of disease and have already helped to guide drug development. Researchers including…

Read More Read More

Nanoelectric device could lead to a diagnostic blood test for ME/CFS

Nanoelectric device could lead to a diagnostic blood test for ME/CFS

Last week, Dr Ron Davis’s team published a pilot study showing remarkable results for their nanoneedle device. Strikingly, there was no overlap between the results for 20 ME/CFS patients and those for 20 healthy controls, something that is almost never seen with this illness. A nanoelectronics-blood-based diagnostic biomarker for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) R Esfandyarpour, A Kashi, M Nemat-Gorgani, J Wilhelmy and RW Davis. 2019 The nanoelectric blood test The research used nanomanufacturing techniques to embed large numbers of…

Read More Read More

Something in the blood

Something in the blood

Remarkaably, four independent groups have now found that a factor in the blood can affect cell metabolism/mitochondria in ME/CFS and transfer the effect to healthy cells.

The first to find the effect were Dr Oystein Fluge and Professor Olav Mella in 2016. They were studying energy production in the cell, a logical thing to do when trying to understand an illness where energy is in such short supply.

%d bloggers like this: